Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online March 29, 2007
Stem Cells Vol. 25 No. 7 July 2007, pp. 1737 -1745
doi:10.1634/stemcells.2007-0054; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0054v1
25/7/1737    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ponte, A. L.
Right arrow Articles by Domenech, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ponte, A. L.
Right arrow Articles by Domenech, J.

TISSUE-SPECIFIC STEM CELLS

The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities

Adriana López Pontea, Emeline Maraisa, Nathalie Gallaya, Alain Langonnéa,b, Bruno Delormea, Olivier Héraulta,c, Pierre Charborda, Jorge Domenecha,c

aLaboratoire d'Hématopoïèse, Institut National de la Santé et de la Recherche Médicale ERI5, IFR135 Université François Rabelais, Tours, France;
bEFS Centre-Atlantique, Tours, France;
cCHRU de Tours, Tours, France

Key Words. Bone marrow • Mesenchymal stem cell • In vitro migration • Growth factors • Chemokines • Tumor necrosis factor {alpha}

Correspondence: Jorge Domenech M.D., Ph.D., Laboratoire d'Hématopoïèse, Inserm-ESPRI-EA3855, Faculté de Médecine, 10 boulevard Tonnellé, 37 032 Tours Cedex, France. Telephone: 33-247-47-47-21; Fax: 33-247-47-69-34; e-mail: domenech{at}med.univ-tours.fr

Received on January 24, 2007; accepted for publication on March 20, 2007.

First published online in STEM CELLS EXPRESS  March 29, 2007.


Adult bone marrow (BM)-derived stem cells, including hematopoietic stem cells (HSCs) and MSCs, represent an important source of cells for the repair of a number of damaged tissues. In contrast to HSCs, the soluble factors able to induce MSC migration have not been extensively studied. In the present work, we compared the in vitro migration capacity of human BM-derived MSCs, preincubated or not with the inflammatory cytokines interleukin 1ß (IL1ß) and tumor necrosis factor {alpha} (TNF{alpha}), in response to 16 growth factors (GFs) and chemokines. We show that BM MSCs migrate in response to many chemotactic factors. The GFs platelet-derived growth factor-AB (PDGF-AB) and insulin-like growth factor 1 (IGF-1) are the most potent, whereas the chemokines RANTES, macrophage-derived chemokine (MDC), and stromal-derived factor-1 (SDF-1) have limited effect. Remarkably, preincubation with TNF{alpha} leads to increased MSC migration toward chemokines, whereas migration toward most GFs is unchanged. Consistent with these results, BM MSCs express the tyrosine kinase receptors PDGF-receptor (R) {alpha}, PDGF-Rß, and IGF-R, as well as the RANTES and MDC receptors CCR2, CCR3, and CCR4 and the SDF-1 receptor CXCR4. TNF{alpha} increases CCR2, CCR3, and CCR4 expression (as opposed to that of CXCR4), together with RANTES membrane binding. These data indicate that the migration capacity of BM MSCs is under the control of a large range of receptor tyrosine kinase GFs and CC and CXC chemokines. Most chemokines are more effective on TNF{alpha}-primed cells. Our results suggest that the mobilization of MSCs and their subsequent homing to injured tissues may depend on the systemic and local inflammatory state.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
Stem CellsHome page
N. Li, X. Lu, X. Zhao, F.-L. Xiang, A. Xenocostas, M. Karmazyn, and Q. Feng
Endothelial Nitric Oxide Synthase Promotes Bone Marrow Stromal Cell Migration to the Ischemic Myocardium via Upregulation of Stromal Cell-Derived Factor-1{alpha}
Stem Cells, April 1, 2009; 27(4): 961 - 970.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. U. Schraufstatter, R. G. DiScipio, M. Zhao, and S. K. Khaldoyanidi
C3a and C5a Are Chemotactic Factors for Human Mesenchymal Stem Cells, Which Cause Prolonged ERK1/2 Phosphorylation
J. Immunol., March 15, 2009; 182(6): 3827 - 3836.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
P. Secchiero, E. Melloni, F. Corallini, A. P. Beltrami, F. Alviano, D. Milani, F. D'Aurizio, M. G. di Iasio, D. Cesselli, G. P. Bagnara, et al.
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Promotes Migration of Human Bone Marrow Multipotent Stromal Cells
Stem Cells, November 1, 2008; 26(11): 2955 - 2963.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Sang, M. S. Curran, and A. W. Wood
Paracrine Insulin-Like Growth Factor Signaling Influences Primordial Germ Cell Migration: In Vivo Evidence from the Zebrafish Model
Endocrinology, October 1, 2008; 149(10): 5035 - 5042.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
L. da Silva Meirelles, A. I. Caplan, and N. B. Nardi
In Search of the In Vivo Identity of Mesenchymal Stem Cells
Stem Cells, September 1, 2008; 26(9): 2287 - 2299.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. R. Loebinger, E. K. Sage, and S. M. Janes
Mesenchymal Stem Cells as Vectors for Lung Disease
Proceedings of the ATS, August 15, 2008; 5(6): 711 - 716.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. M. Sonabend, I. V. Ulasov, M. A. Tyler, A. A. Rivera, J. M. Mathis, and M. S. Lesniak
Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma
Stem Cells, March 1, 2008; 26(3): 831 - 841.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. L. Tomchuck, K. J. Zwezdaryk, S. B. Coffelt, R. S. Waterman, E. S. Danka, and A. B. Scandurro
Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses
Stem Cells, January 1, 2008; 26(1): 99 - 107.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Klopp, E. L. Spaeth, J. L. Dembinski, W. A. Woodward, A. Munshi, R. E. Meyn, J. D. Cox, M. Andreeff, and F. C. Marini
Tumor Irradiation Increases the Recruitment of Circulating Mesenchymal Stem Cells into the Tumor Microenvironment
Cancer Res., December 15, 2007; 67(24): 11687 - 11695.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. Chamberlain, J. Fox, B. Ashton, and J. Middleton
Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing
Stem Cells, November 1, 2007; 25(11): 2739 - 2749.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.